See the full PDF version here: finalcopypharmaletter
I am often asked what my thoughts are on the “fentanyl epidemic” and what impact it will have on Nova Scotia so here it is: Fentanyl is of great concern due to its potency and accessibility vs other prescription opioids. The healthcare system created a huge market of opioid dependant people which organize crime is… Continue reading Illicit Fentanyl’s confirmed arrival in Nova Scotia
Interviews include: Rob Mulloy – GPDOTS enforcement consultant Ray Wagner – Lawyer heading class action suit against Purdue Pharma Nadine Wentzell – Consultant & former narcotics inspector
On March 7th 2016 GPDOTS wrote the Nova Scotia Minister of Health & Wellness , College of Physicians & Surgeons , and the Prescription Monitoring Program regarding our concerns with the programs ability to identify over prescribing. Shortly after our letter Minister Leo Glavine announced he would be ordering a full review of the program.… Continue reading GPDOTS letter of concern regarding the Prescription Monitoring Program
In the first 9 months of 2015 fentanyl killed 215 Albertans. Public health officials, enforcement, and government have sounded the alarm , created task forces, and public awareness campaigns. The sudden spike in fentanyl related deaths has put pressure on the government to make naloxone more accessible, often described as the “fentanyl antidote” in media reports… Continue reading We have an opioid epidemic not a fentanyl epidemic.